Patient recruitment, as the single most time consuming aspect of clinical trials, affords the greatest opportunity to accelerate trials and the drug development process. Faster patient recruitment is a win-win situation for drug companies and patients, alike. Drug companies get their products to market faster, and patients get the treatments they need sooner.